Pulse Biosciences, Inc.
PLSE
$17.19
$0.704.25%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -60.24M | -53.59M | -46.13M | -44.02M | -42.55M |
| Total Depreciation and Amortization | 1.16M | 1.18M | 1.20M | 1.20M | 1.20M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 17.51M | 13.59M | 10.15M | 8.97M | 8.06M |
| Change in Net Operating Assets | 1.48M | 2.47M | 807.00K | -1.59M | -2.97M |
| Cash from Operations | -40.08M | -36.34M | -33.98M | -35.44M | -36.25M |
| Capital Expenditure | -165.00K | -125.00K | -115.00K | -100.00K | -87.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -165.00K | -125.00K | -115.00K | -100.00K | -87.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 1.75M | 917.00K |
| Issuance of Common Stock | 124.92M | 110.42M | 62.97M | 1.53M | 16.21M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -281.00K | -281.00K | -222.00K | -279.00K | -6.00K |
| Cash from Financing | 124.64M | 110.14M | 62.74M | 2.99M | 17.13M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 84.39M | 73.67M | 28.65M | -32.55M | -19.21M |